Panel Series
Photobiomodulation has been studied in veterinary medicine across multiple species, with strong evidence for wound healing, pain management, and post-surgical recovery. This article covers the peer-reviewed research on red light therapy for pets and horses.
Red Light Therapy and Brain Entrainment: Gamma Frequency Protocols
Two emerging fields in neuroscience converged in ways researchers are still working to fully understand: transcranial photobiomodulation (tPBM), which uses near-infrared light to support mitochondrial function in brain tissue, and brain entrainment, which uses rhythmic sensory stimulation to drive neural oscillations at target frequencies. When combined, they offer a compelling approach to cognitive support and neuroprotection.
What Is Brain Entrainment?
Brain entrainment — also called neural entrainment or frequency-following response — refers to the brain's tendency to synchronise its electrical activity with external rhythmic stimuli. This is not metaphorical: EEG recordings clearly show that when the brain is exposed to rhythmic light, sound, or tactile input at a specific frequency, neural oscillations in corresponding brain regions lock to that frequency.
Different neural frequency bands are associated with different cognitive states:
- Delta (0.5–4 Hz): Deep sleep, recovery
- Theta (4–8 Hz): Drowsiness, meditation, memory consolidation
- Alpha (8–12 Hz): Relaxed wakefulness, calm focus
- Beta (12–30 Hz): Active cognition, problem-solving
- Gamma (30–100 Hz, peak ~40 Hz): High-level cognitive processing, working memory, attention, sensory binding
Gamma oscillations at ~40Hz have attracted particular scientific attention because of their role in binding sensory information across brain regions and their documented disruption in neurodegenerative conditions, particularly Alzheimer's disease.
The MIT Tsai Lab Research: 40Hz Light and Alzheimer's
The most significant research on gamma entrainment comes from the laboratory of Professor Li-Huei Tsai at MIT's Picower Institute for Learning and Memory. In a landmark 2016 paper published in Nature, Tsai and colleagues demonstrated that exposing mice to flickering light at exactly 40Hz drove gamma oscillations in the visual cortex and produced dramatic reductions in amyloid-beta peptides — the protein fragments that aggregate into the plaques characteristic of Alzheimer's disease.
The mechanism appeared to involve microglial cells (the brain's immune cells), which increased their activity and clearance of amyloid-beta in response to 40Hz entrainment. Subsequent work extended these findings to the hippocampus (a key memory structure) using combined visual and auditory 40Hz stimulation, and demonstrated reductions in both amyloid-beta and tau pathology.
Key findings from the Tsai lab research program:
- 40Hz visual flicker reduces amyloid-beta levels in the visual cortex by ~40–67% in mouse models
- Combined visual + auditory 40Hz stimulation extends effects to hippocampus and prefrontal cortex
- Chronic 40Hz stimulation (1 hour/day) preserves synaptic density and spatial memory in Alzheimer's model mice
- Human trials (published 2019, 2023) show measurable gamma power increases and preliminary evidence of slowed cognitive decline in early Alzheimer's patients
A Phase 2/3 clinical trial (OVERTURE) with 200+ Alzheimer's patients is ongoing as of 2025, making this one of the most actively studied non-pharmacological Alzheimer's interventions in the field.
Photobiomodulation and the Brain: The tPBM Layer
Separate from the entrainment research, transcranial photobiomodulation (tPBM) using 810nm near-infrared light has its own strong evidence base for cognitive support. NIR light at 810nm penetrates the skull (which is relatively transparent to NIR wavelengths) and is absorbed by cytochrome c oxidase in neurons, boosting ATP production in brain cells.
Clinical studies of tPBM have documented:
- Improved working memory performance in healthy young adults (Barrett & Gonzalez-Lima, 2013)
- Improved attention and processing speed in mild traumatic brain injury (Naeser et al., 2014)
- Reduced depression symptoms in treatment-resistant major depressive disorder (Cassano et al., 2018)
- Improved cognitive function in mild cognitive impairment (Berman et al., 2017)
- Neuroprotective effects in animal models of Parkinson's disease and ALS
The mechanism is complementary to gamma entrainment: while 40Hz light drives neural synchronisation through a top-down oscillatory mechanism, 810nm tPBM supports the underlying energy metabolism that neurons require to maintain those oscillations and perform complex cognitive tasks.
The Combined Protocol: Gamma + tPBM
The most advanced brain optimisation protocols combine both approaches simultaneously:
- 40Hz flickering NIR light drives gamma entrainment while simultaneously delivering tPBM to cortical tissue
- 810nm continuous or pulsed NIR supports mitochondrial function throughout the session
The MitoMIND helmet is designed around this dual-mechanism approach, delivering both 810nm near-infrared light and 40Hz pulsed stimulation in a wearable format that covers the full scalp and prefrontal cortex.
Practical Protocol for Brain Entrainment + tPBM
- Frequency: Daily for cognitive support goals; minimum 5x/week
- Duration: 20–30 minutes per session (consistent with most published tPBM and entrainment protocols)
- Timing: Morning or early afternoon — gamma activity is naturally higher during alert wakefulness; avoid late evening as stimulation may interfere with sleep onset
- Environment: Reduce other visual stimulation during sessions — the entrainment effect is stronger with reduced competing visual input
- Consistency: Most cognitive benefits in human tPBM studies accumulate over weeks to months of daily use, not single sessions
Who This Is For
The evidence supports brain entrainment + tPBM protocols for several populations:
- Cognitive performance optimisation: Healthy adults seeking improved working memory, focus, and mental clarity
- Post-TBI recovery: Published evidence for tPBM in mild TBI with documented cognitive effects
- Early cognitive decline: Emerging evidence from human trials; most appropriate as adjunct to medical care
- Alzheimer's prevention/early intervention: The MIT research suggests preventive use in high-risk individuals warrants investigation
- Mood and resilience: tPBM's documented effects on depression and stress resilience make it relevant for broad mental wellness goals
Note: tPBM and gamma entrainment protocols are not treatments for Alzheimer's disease or any neurological condition. Individuals with diagnosed neurological conditions should work with their healthcare provider. See our contraindications page for important safety information.
Frequently Asked Questions
What is 40Hz brain entrainment?
40Hz brain entrainment uses rhythmic light or sound pulsed at 40 times per second to encourage the brain’s gamma oscillations to synchronise at that same frequency, a process detectable on EEG.
How is 40Hz entrainment different from regular red light therapy?
Standard red light therapy focuses on mitochondrial support through continuous or slow-pulsed light, while 40Hz entrainment specifically targets neural oscillations using gamma-frequency flicker as a neuromodulation signal.
Why combine gamma entrainment with 810nm tPBM?
Gamma entrainment influences network-level brain activity, while 810nm tPBM supports cellular energy production; together they address both neural synchrony and mitochondrial metabolism in the same session.
Who should avoid gamma flicker and tPBM protocols?
People with a history of photosensitive epilepsy, uncontrolled seizures, or other serious neurological conditions should only consider gamma or tPBM protocols under medical supervision and may be advised to avoid them.
How does the MitoMIND helmet fit into these protocols?
The MitoMIND helmet is designed to deliver 810nm near-infrared light with 40Hz pulsing across major cortical regions, aligning with research-informed gamma and tPBM dosing parameters.
References
- Iaccarino HF et al. Gamma frequency entrainment attenuates amyloid load and modifies microglia. Nature. 2016;540(7632):230–235.
- Martorell AJ et al. Multi-sensory gamma stimulation ameliorates Alzheimer's-associated pathology and improves cognition. Cell. 2019;177(2):256–271.
- Barrett DW, Gonzalez-Lima F. Transcranial infrared laser stimulation produces beneficial cognitive and emotional effects in humans. Neuroscience. 2013;230:13–23.
- Naeser MA et al. Significant improvements in cognitive performance post-transcranial red/near-infrared light-emitting diode treatments in chronic mild TBI. J Neurotrauma. 2014;31(11):1008–1017.
- Cassano P et al. Transcranial photobiomodulation for the treatment of major depressive disorder. Neuropsychiatr Dis Treat. 2018;14:2633–2643.
- Salehpour F et al. Brain photobiomodulation therapy: a narrative review. Mol Neurobiol. 2019;56(8):6112–6128.
This article discusses published scientific research and general educational information about photobiomodulation and red light therapy. It does not constitute medical advice and does not make specific claims about Mito Red Light devices. The research cited reflects independent peer-reviewed studies and does not imply that any Mito Red Light product has been evaluated, approved, or cleared by the FDA or any other regulatory body for the diagnosis, treatment, cure, or prevention of any disease or medical condition. Individual results vary. Consult a qualified healthcare professional before beginning any light therapy protocol, particularly if you have a pre-existing medical condition, are pregnant, or are taking photosensitising medications.
Mito Red Light products are general wellness devices. They are not medical devices and have not been evaluated, cleared, or approved by the FDA or any regulatory body for the diagnosis, treatment, cure, or prevention of any disease or medical condition. Any references to peer-reviewed research or clinical studies on this page describe findings from independent scientific literature and do not imply that Mito Red Light devices have been studied, tested, or proven effective for any specific condition. Always consult a qualified healthcare provider before beginning any new wellness routine, particularly if you have a medical condition or are taking medication.
Related articles
More from the brain, mood & cognitive health knowledge cluster